4.4 Article

Prevalence of chronic migraine and medication overuse headache in Germany-the German DMKG headache study

Journal

CEPHALALGIA
Volume 30, Issue 2, Pages 207-213

Publisher

SAGE PUBLICATIONS LTD
DOI: 10.1111/j.1468-2982.2009.01906.x

Keywords

6-month prevalence; chronic migraine; medication overuse headache; body mass index; smoking; drinking

Funding

  1. German Migraine & Headache Society
  2. Astra Zeneca
  3. Berlin Chemie
  4. Boots Healthcare
  5. Glaxo-Smith-Kline
  6. McNeil Pharma, MSD Sharp Dohme
  7. Pfizer
  8. German Federal Ministry of Education and Research [BMBF 01ZZ96030]
  9. Ministry for Education, Research and Cultural Affairs
  10. Ministry for Social Affairs of the Federal State of Mecklenburg-Vorpommern

Ask authors/readers for more resources

Population-based epidemiological studies about the prevalence of chronic migraine using the 2004 International Headache Society (IHS) classification definition are rare. We analysed the data of the Deutsche Migrane und Kopfschmerz Gesellschaft headache study, which included 7417 adults in three regions of Germany, with respect to their headache. Additionally, body mass index, alcohol consumption and smoking behaviour were recorded. Using the IHS definition from 2004, chronic migraine was diagnosed in 0.2% of the population. Half of these patients also fulfilled the criteria of medication overuse headache (MOH). The distribution of migraine attacks per subject was highly skewed, with only 14% of all migraine patients having more than six migraine attacks per month. Patients with chronic migraine or MOH seem more often to be active smokers than controls without headache. A body mass index of >= 30 was present significantly more often in patients with MOH than in controls or in patients with episodic migraine. The skewed distribution of the numbers of attacks per patient supports the recommendation to differentiate between episodic migraine with low and high attack frequency, as is done in the classification of tension-type headache. It further suggests that migraine with high attack frequency might be biologically different. The higher prevalence of smokers and of patients with a body mass index >= 30 in chronic migraine or MOH supports the idea of a frontal dysfunction in these patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available